CLYM
Climb Bio Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$7.03
-0.23 ▼ -3.17%
🌙 3월 13일 4:53 PM ET (한국 3/14 05:53)
$6.83
-0.20 ▼ -2.84%
| Index | - | P/E | - | EPS (ttm) | -0.89 | Insider Own | 12.22% | Shs Outstand | 0.05B | Perf Week | -2.09% |
| Market Cap | 0.34B | Forward P/E | - | EPS next Y | -15.36% | Insider Trans | 3.03% | Shs Float | 0.04B | Perf Month | 26.44% |
| Enterprise Value | 0.24B | PEG | - | EPS next Q | -0.27 | Inst Own | 73.91% | Short Float | 4.18% | Perf Quarter | 237.98% |
| Income | -0.06B | P/S | - | EPS this Y | -21.74% | Inst Trans | 9.79% | Short Ratio | 1.43 | Perf Half Y | 192.92% |
| Sales | 0.00B | P/B | 2.09 | EPS next 5Y | -17.83% | ROA | -31.1% | Short Interest | 1.75M | Perf YTD | 75.75% |
| Book/sh | 3.36 | P/C | 3.32 | EPS past 3/5Y | 19.93% -0.24% | ROE | -32.15% | 52W High | -12.56% ($8.04) | Perf Year | 428.57% |
| Cash/sh | 2.12 | P/FCF | - | Sales past 3/5Y | - | ROIC | -37.23% | 52W Low | 569.52% ($1.05) | Perf 3Y | 155.64% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 58.37% | Gross Margin | - | Volatility(W/M) | 9.3% 8.68% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.57 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 15.16 | EPS Q/Q | -107.83% | Profit Margin | - | RSI (14) | 61.58 | Recom | 1.1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 15.16 | Sales Q/Q | - | SMA20 | 4.87% ($6.7) | Beta | -0.24 | Target Price | $14 |
| Payout | - | Debt/Eq | 0 | Earnings | 3000000 | SMA50 | 28.42% ($5.47) | Rel Volume | 0.36 | Prev Close | $7.26 |
| Employees | 28 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -31.78% - | SMA200 | 146.17% ($2.86) | Avg Volume(3M) | 1.23M | Price | $7.03 |
| IPO | 2021/8/10 | Option/Short | Yes/Yes | Trades | 3084 | Volume | 446,011 | Change | -3.17% |
뉴스 로딩 중...